|
FY2023
12 months to Jan 31, 2023
|
FY2022
12 months to Jan 31, 2022
|
FY2021
12 months to Dec 31, 2020
|
FY2020
8 months to Dec 31, 2019
|
|
|---|---|---|---|---|
| Cash flows from operating activities | ||||
| Net income (loss) | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Interest earned on marketable securities held in Trust Account | ||||
| Deferred tax provision (benefit) | ||||
| Depreciation and amortization | ||||
| Gain on sale of fixed assets | ||||
| Loss of disposal of fixed assets | ||||
| Bad debt expense | ||||
| Employee stock based compensation | ||||
| Change in fair value of warrants liabilities | ||||
| Change in fair value of conversion options | ||||
| Change in fair value of commitment fee | ||||
| Conversion option accretion | ||||
| Non-cash interest expense | ||||
| Non-cash interest income on amounts due from stockholder | ||||
| Excess inventory adjustment | ||||
| Changes in operating assets and liabilities: | ||||
| Accounts receivable | ||||
| Accounts and related party receivable | ||||
| Deferred costs | ||||
| Inventories | ||||
| Prepaid expenses | ||||
| Accounts payable and accrued expenses | ||||
| Income taxes payable | ||||
| Other current assets | ||||
| Prepaid warranty | ||||
| Deposits and other assets | ||||
| Accounts payable | ||||
| Accrued expenses | ||||
| Income tax payable | ||||
| Other liabilities | ||||
| Deferred rent | ||||
| Deferred revenue | ||||
| Warrants | ||||
| Operating lease liability | ||||
| Net cash used in operating activities | ||||
| Cash flows from investing activities | ||||
| Cash withdrawn from Trust Account to pay franchise taxes | ||||
| Purchases of property and equipment | ||||
| Capitalized software development costs | ||||
| Proceeds from the sale of fixed assets | ||||
| Proceeds from the maturity of investments | ||||
| Net cash used in investing activities | ||||
| Cash flows from financing activities | ||||
| Exercise of stock options | ||||
| Statutory tax withholding related to net-share settlement of restricted stock units | ||||
| Cash received to fund employee tax obligation for vested RSUs | ||||
| Cash remitted to fund employee tax obligation for vested RSUs | ||||
| Payment of equity line commitment fee | ||||
| Proceeds from issuance of convertible notes | ||||
| Proceeds from issuance of related party debt | ||||
| Payment of debt issuance costs | ||||
| Repayment of debt | ||||
| Payment of finance lease obligations | ||||
| Proceeds from issuance of common stock | ||||
| Proceed from borrowing SVB Bridge loan | ||||
| Proceeds from borrowing of PPP loan | ||||
| Proceeds from borrowing under SVB bridge loan | ||||
| Payment of SVB bridge loan | ||||
| Payment of PPP loan | ||||
| Merger recapitalization | ||||
| Proceeds from issuance of PIPE shares | ||||
| Payment of transaction costs | ||||
| Payment of merger transaction costs | ||||
| Proceeds from stock subscriptions | ||||
| Net cash provided by financing activities | ||||
| Net Change in Cash | ||||
| Cash – April 30, 2019 (inception) | ||||
| Cash – Ending | ||||
| Cash – Beginning | ||||
| Cash – Ending | ||||
| Effect of exchange rate changes on cash and cash equivalents | ||||
| Net change in cash and cash equivalents | ||||
| Cash and Cash Equivalents | ||||
| Beginning of the period | ||||
| End of the period | ||||
| Supplemental disclosure of cash flow information | ||||
| Cash paid for interest | ||||
| Supplemental disclosures of non-cash investing and financing activities | ||||
| Change in value of common stock subject to possible redemption | ||||
| Interest earned on subscription notes receivable | ||||
| Unpaid purchases of property and equipment | ||||
| Non-cash settlement of related party loan receivable for common shares | ||||
| Initial classification of warrant liabilities | ||||
| Cashless exercise of warrants classified as liabilities | ||||
Loading...